To help hospitals reduce preventable errors and cut down costs in litigation, Scalpel Ltd. is building an end to end patient safety platform. This AI-powered platform checks and verifies the implementation of safety steps during surgery using a combination of computer vision and machine learning technologies. Unlike standard checklists, Scalpel’s solution doesn’t require any human interaction. Sitting in the background in an operating room it automatically monitors the process and provides real-time feedback to detect and prevent errors.
Parallel Carbon is creating the hardware platform required for a post-fossil-fuel society. To eliminate emissions, they are developing technology that removes carbon dioxide from the atmosphere while producing hydrogen. Their mission is to provide the most scalable solution to climate change.
Ancilia Biosciences develops engineered bacterial therapies to treat diseases linked to the microbiome. It provides and develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications.
Aquature is creating a decentralized platform to assist enterprises in transitioning to sustainable wastewater treatment, saving money and gaining independence through the advancement of circularity concepts .Aquature designs, owns, installs and operates your wastewater treatment system with no upfront capital investment. They only pay a service charge per cubic metre of wastewater treated and for the green chemicals you want to recirculate and use in your process.